Perhaps you think it's impossible to score another 1,000% gain off this "tech titan" stock. Think again. An unusual strategy lets you virtually "recreate" gains off the biggest companies you thought had come and gone. CLICK HERE to see how it works.
Market Volatility Fraught with Danger
by The Investment U Research Team
It’s one thing to ride a wave going up, or to ride one going straight down. It’s an entirely different story to be caught in turbulent water that’s churning up and down without warning. And it’s where many investors are finding themselves this week.
…a little seasick.
With the news of the banking stress tests, swine influenza, and the dismantling of our automakers, the markets are balancing a lot of negativity with a surprising amount of consumer optimism. It may be the only thing buoying the markets right now.
Painfully, many investors who have rushed back into the markets over the past month may now find themselves having bought at the peak of a bear market rally. They’ll get to watch their holdings sink down again.
If this happens, it could have a chilling effect on the mindsets of many investors. And the net result is that it will prolong the recovery and the return to “business as usual.”
So we’re looking at the current juncture in the markets as being fraught with more danger than many want to admit. It’s not the monetary damage, it’s the emotional impact.
A good example of what kind of tipping point we’re at is the price of crude oil. It’s been flirting with $50 for a while now. But that may be the artificial price the markets have “agreed” on until things change in the global economic picture.
But even at $50 it may already be too expensive.
And if demand doesn’t increase, we could see this artificial price point slide lower. Inventories are piling up – in the United States and in Europe. At some point if that doesn’t stop, the economics will do what the traders are not: force oil prices down.
- Sweet, Sweet Rebound… Or is it
- Markets Take a Nosedive
- Will The Price of Oil Per Barrel Drop to $20?
|
The Company Set to Dominate a $60 Billion-a-Year Market
$60 billion is spent on cancer treatment in the U.S. - each year. And one company is poised to receive the lion's share of it.
The medical director at the Alta Bates Comprehensive Cancer Center says, "...possibly a third of our cancer patient population will soon be undergoing this [company's] treatment."
Another doctor at the University of Texas MD Anderson Cancer Center says he intends to treat over 1,000 patients a year with this technology.
Here's how you can claim your stake in the company before this cash infusion sends shares soaring.
Comments
**By submitting your comment you agree to adhere to our Comment Policy and Privacy Policy.Check out our selection of daily Investment Research:
 |
 |
Investment U RSS Feed